Latest Insider Transactions at Matinas Bio Pharma Holdings, Inc. (MTNB)
This section provides a real-time view of insider transactions for Matinas Bio Pharma Holdings, Inc. (MTNB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Matinas BioPharma Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Matinas BioPharma Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2022
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
1,358,122
+22.44%
|
-
|
|
Jun 22
2022
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Indirect |
1,358,122
-100.0%
|
-
|
|
Dec 31
2021
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,859
+2.63%
|
-
|
|
Sep 30
2021
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,106
+2.11%
|
-
|
|
Sep 03
2021
|
Raphael J Mannino Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
462,150
+19.4%
|
-
|
|
Aug 04
2021
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
494,622
+12.91%
|
-
|
|
Aug 04
2021
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Direct |
494,622
-100.0%
|
-
|
|
Jul 07
2021
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
1,280,917
+31.07%
|
-
|
|
Jul 07
2021
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Indirect |
1,280,917
-48.54%
|
-
|
|
Jun 30
2021
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,244
+3.57%
|
-
|
|
Jun 19
2021
|
Raphael J Mannino Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
20,000
+1.35%
|
-
|
|
Jun 19
2021
|
Raphael J Mannino Chief Scientific Officer |
BUY
Other acquisition or disposition
|
Direct |
8,000
+0.55%
|
-
|
|
Jun 19
2021
|
Herbert J Conrad Director |
BUY
Conversion of derivative security
|
Indirect |
200,000
+11.36%
|
-
|
|
Jun 19
2021
|
Herbert J Conrad Director |
BUY
Other acquisition or disposition
|
Indirect |
40,000
+2.86%
|
-
|
|
Jun 19
2021
|
Matthew Wikler Director |
BUY
Conversion of derivative security
|
Direct |
12,000
+4.31%
|
-
|
|
Jun 19
2021
|
Matthew Wikler Director |
BUY
Other acquisition or disposition
|
Direct |
2,400
+0.94%
|
-
|
|
Jun 19
2021
|
James S Scibetta Director |
BUY
Conversion of derivative security
|
Direct |
24,000
+3.56%
|
-
|
|
Jun 19
2021
|
James S Scibetta Director |
BUY
Other acquisition or disposition
|
Direct |
4,800
+0.76%
|
-
|
|
Jun 19
2021
|
Jerome D Jabbour President and CEO |
BUY
Conversion of derivative security
|
Direct |
30,000
+3.45%
|
-
|
|
Jun 19
2021
|
Jerome D Jabbour President and CEO |
BUY
Other acquisition or disposition
|
Direct |
6,000
+0.74%
|
-
|
|
Jun 19
2021
|
Eric J Ende Director |
BUY
Conversion of derivative security
|
Direct |
24,000
+14.28%
|
-
|
|
Jun 19
2021
|
Eric J Ende Director |
BUY
Other acquisition or disposition
|
Direct |
4,800
+3.84%
|
-
|
|
May 20
2021
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
1,145,905
+46.45%
|
-
|
|
May 20
2021
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Indirect |
1,145,905
-100.0%
|
-
|
|
Mar 31
2021
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,560
+2.91%
|
-
|
|
Jan 13
2021
|
Herbert J Conrad Director |
BUY
Bona fide gift
|
Indirect |
50,000
+22.22%
|
-
|
|
Jan 13
2021
|
Herbert J Conrad Director |
SELL
Bona fide gift
|
Direct |
50,000
-9.18%
|
-
|
|
Dec 31
2020
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,673
+4.56%
|
-
|
|
Sep 30
2020
|
Matthew Wikler Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,725
+8.18%
|
-
|